ArticleBreast cancer research and treatment2016

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients.

Sasagu Kurozumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.